News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety Alerts Gabapentin and Pregabalin Potential for Misuse Public Health England and NHS England have published advice for prescribers on the risk of misuse of gabapentin and pregabalin. For more information, click here.   Hot Topics Drugs […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety alerts Naloxone – Patient Safety Alert NHS England has produced a Patient Safety Alert warning of the risk of distress and death from inappropriate doses of naloxone in patients on long-term opioid treatment (NHS/PSA/W/2014/016R). The alert […]

Read More…

SHORTCUTS

Eur J Pain. 2014 Aug 4. doi: 10.1002/ejp.567. [Epub ahead of print] A systematic review of therapeutic interventions to reduce acute and chronic post-surgical pain after amputation, thoracotomy or mastectomy Humble SR, Dalton AJ, Li L In this systematic review of perioperative interventions reducing acute and chronic pain associated with amputation, mastectomy or thoracotomy, 32 […]

Read More…

Letter to the Editor – The use of the Deprivation of Liberty Safeguards in Palliative Care and the Cheshire West judgment: A Missed Opportunity?

  To the Editor, The Deprivation of Liberty Safeguards (DoLS) were introduced on the 1st April 2009 to provide a framework for the lawful detention of individuals in hospitals (including hospices) or care homes who are unable to consent to their placement.1 The DoLS have come under increased scrutiny this year due to the Supreme Court […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Drug updates Nitrofurantoin contra-indications updated The guidance for using nitrofurantoin in renal impairment has changed. Nitrofurantoin is now contra-indicated in patients with an estimated glomerular filtration rate (eGFR) of <45mL/min/1.73m2. However, a short course (3–7 days) may be […]

Read More…

Palliating Social Media – a seminar workshop at the Macmillan Professionals Conference in London

Dr Clifford Jones a Macmillan GP Facilitator in Aneurin Bevan Healthboard summarises a workshop seminar he attended at a Macmillan GP conference in London.   Conference Twitter hashtag: #Macmillanpros What happens to our presence on social media when we die? And how do palliative care patients and professionals use social media?  These were some of […]

Read More…

SHORTCUTS

Cancer Med. 2014 Aug 26. doi: 10.1002/cam4.316. [Epub ahead of print] Incidence and risk factors for suicide and attempted suicide following a diagnosis of hematological malignancy Hultcrantz M, Svensson T, Derolf AR, Kristinsson SY, Lindqvist EK, Ekbom A, Granath F, Björkholm M In this Swedish population-based study of nearly 50,000 patients with haematological malignancies and […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety alerts Dexamethasone 4mg/mL injection changes Dexamethasone injection 4mg/mL (Organon) has been acquired by Aspen pharmaceuticals. They have reformulated the product and it now contains 3.8mg/mL dexamethasone, available as a 1mL vial, which requires storage in a […]

Read More…